ROTHSCHILD INVESTMENT LLC /IL - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$223,000
+10.9%
2,800
+40.7%
0.03%
-3.7%
Q4 2018$201,000
-19.9%
1,9900.0%0.03%
-10.0%
Q3 2018$251,000
-33.4%
1,990
-55.7%
0.03%
-36.2%
Q2 2018$377,000
+18.6%
4,490
-13.1%
0.05%
+14.6%
Q1 2018$318,000
+5.3%
5,1640.0%0.04%
+24.2%
Q4 2017$302,000
-10.9%
5,164
-11.7%
0.03%
-13.2%
Q3 2017$339,000
-41.6%
5,846
+22.0%
0.04%
-42.4%
Q2 2017$580,000
+7.0%
4,7920.0%0.07%
+4.8%
Q1 2017$542,000
+81.3%
4,792
+74.1%
0.06%
+75.0%
Q4 2016$299,000
-31.4%
2,752
+3.8%
0.04%
-32.1%
Q3 2016$436,000
+15.3%
2,6520.0%0.05%
+10.4%
Q2 2016$378,000
+10.9%
2,6520.0%0.05%
+9.1%
Q1 2016$341,000
-13.9%
2,6520.0%0.04%
-12.0%
Q4 2015$396,000
-10.0%
2,6520.0%0.05%
-13.8%
Q3 2015$440,000
-16.8%
2,652
+21.0%
0.06%
-4.9%
Q2 2015$529,000
-14.4%
2,1920.0%0.06%
-15.3%
Q1 2015$618,000
+80.7%
2,1920.0%0.07%
+75.6%
Q4 2014$342,0002,1920.04%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders